Trial intelligence / Profile preview

Vitamin D3 Supplementation for Pre-eclampsia Risk

NCT03101150Phase 2Completed

Sponsor
King Fahd Medical City
Start
Oct 2012
Primary completion
Oct 2014
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
01

Overview

A Phase 2 trial of vitamin d in preeclampsia, sponsored by King Fahd Medical City. Started Oct 2012; status: completed.

02

Drugs

vitamin d
03

Conditions

preeclampsia

Beyond the preview

Go deeper on NCT03101150.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03101150.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call